Markets:

Overview

News

Currencies

International

Treasuries

Spectrum Pharmaceuticals, Inc. - Common Stock (NQ:SPPI)

N/A UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 31, 2023 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Spectrum Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >

HC Wainwright & Co. Maintains Buy Rating for Spectrum Pharmaceuticals: Here's What You Need To Know ↗

September 12, 2022

HC Wainwright & Co. has decided to maintain its Buy rating of Spectrum Pharmaceuticals (NASDAQ:SPPI) and raise its price target from $10.00 to $12.00. Shares of Spectrum Pharmaceuticals are trading up...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 12, 2022

Via Benzinga

Bristol-Myers Squibb, Carvana And Some Other Big Stocks Recording Gains In Today's Pre-Market Session ↗

September 12, 2022

U.S. stock futures traded higher this morning after recording gains in the previous session. Here are some big stocks moving higher in today’s pre-market trading session.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

September 12, 2022

We're starting off the week with a breakdown of the biggest pre-market stock movers for Monday morning and the news moving them.

Via InvestorPlace

Earnings Scheduled For August 11, 2022 ↗

August 11, 2022

Companies Reporting Before The Bell • Magic Software (NASDAQ:MGIC) is projected to report quarterly earnings at $0.27 per share on revenue of $131.70 million.

Via Benzinga

Why Clovis Oncology Is Trading Higher By 14%; Here Are 28 Stocks Moving Premarket ↗

September 12, 2022

Gainers Aditxt, Inc. (NASDAQ: ADTX) rose 46.1% to $0.2801 in pre-market trading after jumping 37% on Friday.

Via Benzinga

Important Biotech Catalysts For September 9, 2022 - End Of The Day Summary ↗

September 09, 2022

Via Benzinga

Spectrum Gets FDA Nod For Febrile Neutropenia Candidate, Sees Commercial Launch In Q4 2022 ↗

September 09, 2022

The U.S. Food and Drug Administration (FDA) has approved Spectrum Pharmaceuticals’ (NASDAQ: SPPI) lead asset ROLVEDON (eflapegrastim-xnst) injection to decrease the incidence of infection, as...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 08, 2022

Good morning! It's time for another overview of the biggest pre-market stock movers as we see what's happening on Thursday!

Via InvestorPlace

Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know ↗

August 31, 2022

After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

June 30, 2022

We're starting off Thursday with a breakdown of the biggest pre-market stock movers traders will want to keep an eye on!

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

June 21, 2022

Gainers

Via Benzinga

Spectrum Pharmaceuticals: Q1 Earnings Insights ↗

May 12, 2022

Spectrum Pharmaceuticals (NASDAQ:SPPI) reported its Q1 earnings results on Thursday, May 12, 2022 at 04:00 PM. Here's what investors need to know about the announcement.

Via Benzinga

The Daily Biotech Pulse: Bristol Myers, BridgeBio Ink Oncology Pact, FDA Nod For Lava Therapeutics Blood Cancer Study And More ↗

May 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Spectrum Pharmaceuticals's Earnings Outlook ↗

May 11, 2022

Spectrum Pharmaceuticals (NASDAQ:SPPI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement. Analysts estimate that...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 21, 2022

Via Benzinga

Earnings Scheduled For May 12, 2022 ↗

May 12, 2022

Companies Reporting Before The Bell • Chicago Atlantic Real (NASDAQ:REFI) is projected to report earnings for its first quarter.

Via Benzinga

60 Biggest Movers From Yesterday ↗

April 22, 2022

Gainers Cyngn Inc. (NASDAQ: CYN) shares jumped 96.3% to close at $2.12 on Thursday after the company announced the official launch of DriveMod Kit, a turnkey autonomous vehicle...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

April 11, 2022

Rise and shine, investor! It's time to start off another week of trading with the biggest pre-market stock movers for Monday!

Via InvestorPlace

58 Biggest Movers From Yesterday ↗

March 24, 2022

Gainers Allego N.V. (NYSE: ALLG) shares surged 114.1% to close at $17.73 on Wednesday after the company announced the completion of its merger agreement with Spartan Acquisition...

Via Benzinga

38 Stocks Moving In Wednesday's Mid-Day Session ↗

March 23, 2022

Gainers Allego N.V. (NYSE: ALLG) shares jumped 158.5% to $21.41 after the company announced the completion of its merger agreement with Spartan Acquisition Corp., which resulted...

Via Benzinga

32 Stocks Moving in Wednesday's Pre-Market Session ↗

March 23, 2022

Gainers Zentek Ltd. (NASDAQ: ZTEK) rose 180.5% to $7.63 in pre-market trading after declining around 5% on Tuesday. Creative Realities Inc (NASDAQ: CREX) shares rose 52.6% to $1....

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 22, 2022

Grab your cup of coffee, investor! We're starting off the day with a dive into the biggest pre-market stock movers for Tuesday!

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Intraday Session ↗

March 21, 2022

Gainers

Via Benzinga

75 Biggest Movers From Yesterday ↗

March 22, 2022

Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) shares jumped 299.4% to close at $6.23 on Monday as the company received clearance from the FDA to initiate a pharmacokinetic...

Via Benzinga

28 Stocks Moving in Monday's Pre-Market Session ↗

March 21, 2022

Gainers BitNile Holdings, Inc. (NYSE: NILE) rose 61.1% to $0.90 in pre-market trading. BitNile's TurnOnGreen resumed expansion of its electric vehicle charging network and e-...

Via Benzinga

46 Stocks Moving In Monday's Mid-Day Session ↗

March 21, 2022

Gainers NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) climbed 369% to $7.32 as the company received clearance from the FDA to initiate a pharmacokinetic study of PrimeC in...

Via Benzinga

HC Wainwright Sees Almost 1000% Upside On Spectrum Pharma Stock ↗

March 18, 2022

HC Wainwright reiterates the Buy rating on Spectrum Pharmaceuticals Inc (NASDAQ: SPPI), with a price target of $10. The analyst projects revenues of $170...

Via Benzinga

Spectrum Pharmaceuticals: Q4 Earnings Insights ↗

March 17, 2022

Spectrum Pharmaceuticals (NASDAQ:SPPI) reported its Q4 earnings results on Thursday, March 17, 2022 at 04:00 PM. Here's what investors need to know about the announcement....

Via Benzinga

The Daily Biotech Pulse: AbbVie's Rinvoq Gets Label Expansion, AstraZeneca COVID Antibody Cocktail Authorized By UK Regulator, Stealth Touts Positive Data ↗

March 17, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Spectrum Pharmaceuticals, Inc. - Common Stock (NQ:SPPI)

Headline News about Spectrum Pharmaceuticals, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today